SK Biopharm - Clear Signs of Overshooting
In this insight, we discuss the clear signs of overshooting at SK Biopharmaceuticals (326030 KS)'s share price, which has now catapulted as the...
519 Views
Netmarble Corp (SoTP Valuation Analysis) - Impact of Big Hit Entertainment
Our SoTP valuation of Netmarble Corp suggests a NAV of 11.7 trillion won or 135,828 won per share, representing a 16.1% higher upside versus...
439 Views
SK Biopharmaceuticals: KOSPI 200 Inclusion Event
SK Biopharm is currently hitting the daily ceiling at ₩127,000.It is a whopping 160% increase from the IPO price of ₩49,000. Well, the opening...
602 Views
Do What the Locals Do - BUY Celltrion/Samsung Bio/SK Holdings on SK Biopharma Listing
Local institutions in Korea will have a significant underperformance on SK Biopharm listing and will clamor to buy and makeup for their...
455 Views
SK Biopharmaceuticals: Immediate Post IPO Float Is 13% (Not 5%)
What's the post-IPO float of SK Biopharm?It is much higher than what it first appeared after the book-building.Below is the final allocation....
544 Views